S Genovesi1, P Fabbrini2, F Pieruzzi2, E Galbiati2, E Sironi2, D Pogliani3, G Bonforte4, M R Viganò2, A Stella2. 1. Department of Health Sciences, University of Milano-Bicocca and Nephrology Unit San Gerardo Hospital, Via Cadore 48, 20900, Monza (MB), Italy. simonetta.genovesi@unimib.it. 2. Department of Health Sciences, University of Milano-Bicocca and Nephrology Unit San Gerardo Hospital, Via Cadore 48, 20900, Monza (MB), Italy. 3. Nephrology Unit, Antonio Abate Hospital, Varese, Italy. 4. Nephrology Unit, Beata Vergine Hospital, Mendrisio, Switzerland.
Abstract
BACKGROUND: Prevalence and incidence of atrial fibrillation (AF) are high in hemodialysis (HD) patients. Intra-atrial conduction velocity slowing plays an important role in AF onset. The aim of our study was to measure P wave duration (Pwd), expression of intra-atrial conduction velocity, in HD patients with and without a history of AF. METHODS: The study was performed in 47 end stage renal disease (ESRD) patients, subdivided into four groups: 19 patients within the first 6 months from starting HD therapy (HD1); the same patients studied 18 ± 3 months later (HD2); patients with no history of AF and long dialytic age (HD3, n = 13); and patients with sinus rhythm but history of AF (HDAF, n = 15); and 18 healthy controls. In all patients P wave high resolution recording and electrolyte plasma values were obtained before and after a HD session, and atrial diameter was assessed by echocardiography. RESULTS: Patients with the shortest dialysis vintage showed the shortest Pwd [131.2 ± 11.0 (HD1) vs. 139.8 ± 11.7 (HD2), 142.1 ± 7.2 (HD3), 152.3 ± 15.0 (HDAF) ms; p < 0.05], while Pwd was prolonged in patients with AF history when compared to all other groups (p < 0.03). At multivariate analysis atrial dimension was independently related to Pwd (R = 0.40, p < 0.02). HD session induced a significant increase of Pwd (141 ± 14.0-152 ± 17.0 ms, p < 0.001), that was correlated to modifications of K(+) concentration (R = 0.8, p < 0.0001). CONCLUSIONS: HD therapy prolongs Pwd. HD patients with a history of AF have prolonged Pwd compared to patients without, suggesting that increased Pwd is a marker of AF risk in patients with ESRD. HD session acutely increases Pwd, creating conditions favoring AF onset.
BACKGROUND: Prevalence and incidence of atrial fibrillation (AF) are high in hemodialysis (HD) patients. Intra-atrial conduction velocity slowing plays an important role in AF onset. The aim of our study was to measure P wave duration (Pwd), expression of intra-atrial conduction velocity, in HDpatients with and without a history of AF. METHODS: The study was performed in 47 end stage renal disease (ESRD) patients, subdivided into four groups: 19 patients within the first 6 months from starting HD therapy (HD1); the same patients studied 18 ± 3 months later (HD2); patients with no history of AF and long dialytic age (HD3, n = 13); and patients with sinus rhythm but history of AF (HDAF, n = 15); and 18 healthy controls. In all patients P wave high resolution recording and electrolyte plasma values were obtained before and after a HD session, and atrial diameter was assessed by echocardiography. RESULTS:Patients with the shortest dialysis vintage showed the shortest Pwd [131.2 ± 11.0 (HD1) vs. 139.8 ± 11.7 (HD2), 142.1 ± 7.2 (HD3), 152.3 ± 15.0 (HDAF) ms; p < 0.05], while Pwd was prolonged in patients with AF history when compared to all other groups (p < 0.03). At multivariate analysis atrial dimension was independently related to Pwd (R = 0.40, p < 0.02). HD session induced a significant increase of Pwd (141 ± 14.0-152 ± 17.0 ms, p < 0.001), that was correlated to modifications of K(+) concentration (R = 0.8, p < 0.0001). CONCLUSIONS:HD therapy prolongs Pwd. HDpatients with a history of AF have prolonged Pwd compared to patients without, suggesting that increased Pwd is a marker of AF risk in patients with ESRD. HD session acutely increases Pwd, creating conditions favoring AF onset.
Entities:
Keywords:
Atrial dimension; Atrial fibrillation; End stage renal disease; Hemodialysis; P wave duration; Potassium
Authors: Thomas J van Brakel; Thomas van der Krieken; Sjoerd W Westra; Jeroen A van der Laak; Joep L Smeets; Henry A van Swieten Journal: J Interv Card Electrophysiol Date: 2013-09-12 Impact factor: 1.900
Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: Martin Wolfgang Krueger; Stefano Severi; Kawal Rhode; Simonetta Genovesi; Frank Michael Weber; Antonio Vincenti; Paolo Fabbrini; Gunnar Seemann; Reza Razavi; Olaf Dössel Journal: J Electrocardiol Date: 2011 Mar-Apr Impact factor: 1.438
Authors: M S Buiten; M K de Bie; J I Rotmans; B A Gabreëls; W van Dorp; R Wolterbeek; S A Trines; M J Schalij; J W Jukema; T J Rabelink; L van Erven Journal: Heart Date: 2014-03-26 Impact factor: 5.994
Authors: Tara I-Hsin Chang; Sai Liu; Medha Airy; Jingbo Niu; Mintu P Turakhia; Jennifer E Flythe; Maria E Montez-Rath; Wolfgang C Winkelmayer Journal: Clin J Am Soc Nephrol Date: 2019-06-07 Impact factor: 8.237
Authors: Andrzej Jaroszyński; Anna Jaroszyńska; Wojciech Dąbrowski; Tomasz Zaborowski; Andrzej Stepulak; Marek Iłżecki; Tomasz Zubilewicz Journal: Arch Med Sci Date: 2017-02-22 Impact factor: 3.318